Aspire Biopharma Holdings, Inc.
ASBP
$8.87
-$0.38-4.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5,800.63% | 334.98% | 27,786.11% | 11,707.88% | 952.04% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 28.96% | 43.80% | -61.84% | 150.39% | 2,510.67% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1,260.98% | 262.10% | 786.62% | 1,206.03% | 1,894.76% |
|
|
|||||
| Total Current Assets | 1,260.98% | 262.10% | 786.62% | 1,206.03% | 1,894.76% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1,268.56% | 262.10% | 786.62% | 1,206.03% | -80.44% |
|
|
|||||
| Total Accounts Payable | -28.08% | -40.09% | 227.01% | 719.86% | 736.90% |
| Total Accrued Expenses | -2.43% | 18.23% | -- | -- | -- |
| Short-term Debt | -- | -77.84% | 308.53% | 910.98% | 1,802.42% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -63.06% | 114,554.84% | -- |
| Total Other Current Liabilities | -- | -- | -63.06% | 114,554.84% | -- |
| Total Current Liabilities | -84.03% | -64.46% | 349.78% | 1,306.30% | 1,281.25% |
|
|
|||||
| Total Current Liabilities | -84.03% | -64.46% | 349.78% | 1,306.30% | 1,281.25% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -77.84% | 308.53% | 910.98% | 1,802.42% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 95.74% | 95.33% | -- | -- | -98.72% |
| Total Liabilities | -83.19% | -63.57% | 355.45% | 1,307.31% | 129.73% |
|
|
|||||
| Common Stock & APIC | 292.55% | 191.94% | 1,587.96% | 795.89% | 395.42% |
| Retained Earnings | -53.38% | -62.84% | -881.50% | -1,006.11% | -1,053.13% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 222.26% | 155.64% | -314.02% | -1,330.55% | -2,275.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 222.26% | 155.64% | -314.02% | -1,330.55% | -2,275.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 222.26% | 155.64% | -314.02% | -1,330.55% | -2,275.75% |
|
|
|||||